Cancer Drugs
Bavencio
Also known as: Avelumab, Anti-PD-L1
Definition
Avelumab, a PD-L1 inhibitor used in Merkel cell carcinoma and as first-line maintenance in advanced urothelial carcinoma.
Detailed Explanation
Bavencio targets PD-L1 to restore immune response against tumors. It is combined with axitinib for renal cell carcinoma and used after chemotherapy in bladder cancer.